These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34985760)

  • 1. Use of beta-blockers and risk of contralateral breast cancer.
    Gottschau M; Bens A; Friis S; Cronin-Fenton D; Aalborg GL; Jensen MB; Ejlertsen B; Kroman N; Mellemkjaer L
    Int J Cancer; 2022 May; 150(10):1619-1626. PubMed ID: 34985760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonaspirin NSAIDs and contralateral breast cancer risk.
    Bens A; Cronin-Fenton D; Dehlendorff C; Jensen MB; Ejlertsen B; Kroman N; Friis S; Mellemkjaer L
    Int J Cancer; 2019 Mar; 144(6):1243-1250. PubMed ID: 30362513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose aspirin use and risk of contralateral breast cancer: a Danish nationwide cohort study.
    Bens A; Friis S; Dehlendorff C; Jensen MB; Ejlertsen B; Kroman N; Cronin-Fenton D; Mellemkjær L
    Prev Med; 2018 Nov; 116():186-193. PubMed ID: 30261243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of β-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study.
    Sørensen GV; Ganz PA; Cole SW; Pedersen LA; Sørensen HT; Cronin-Fenton DP; Garne JP; Christiansen PM; Lash TL; Ahern TP
    J Clin Oncol; 2013 Jun; 31(18):2265-72. PubMed ID: 23650417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality after contralateral breast cancer in Denmark.
    Langballe R; Frederiksen K; Jensen MB; Andersson M; Cronin-Fenton D; Ejlertsen B; Mellemkjær L
    Breast Cancer Res Treat; 2018 Sep; 171(2):489-499. PubMed ID: 29948403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of H1 antihistamines in contralateral breast cancer: a Danish nationwide cohort study.
    Bens A; Dehlendorff C; Friis S; Cronin-Fenton D; Jensen MB; Ejlertsen B; Lash TL; Kroman N; Mellemkjær L
    Br J Cancer; 2020 Mar; 122(7):1102-1108. PubMed ID: 32063603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-Blockers for Exams Identify Students at High Risk of Psychiatric Morbidity.
    Butt JH; Dalsgaard S; Torp-Pedersen C; Køber L; Gislason GH; Kruuse C; Fosbøl EL
    J Child Adolesc Psychopharmacol; 2017 Apr; 27(3):266-273. PubMed ID: 27782771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-diagnostic beta blocker use and breast cancer-specific mortality: a population-based cohort study.
    Scott OW; Tin Tin S; Elwood JM; Cavadino A; Habel LA; Kuper-Hommel M; Campbell I; Lawrenson R
    Breast Cancer Res Treat; 2022 May; 193(1):225-235. PubMed ID: 35286523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for contralateral breast cancer in postmenopausal breast cancer survivors in the NIH-AARP Diet and Health Study.
    Ramin C; Mullooly M; Schonfeld SJ; Advani PG; Bodelon C; Gierach GL; Berrington de González A
    Cancer Causes Control; 2021 Aug; 32(8):803-813. PubMed ID: 33877513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts.
    Cardwell CR; Pottegård A; Vaes E; Garmo H; Murray LJ; Brown C; Vissers PA; O'Rorke M; Visvanathan K; Cronin-Fenton D; De Schutter H; Lambe M; Powe DG; van Herk-Sukel MP; Gavin A; Friis S; Sharp L; Bennett K
    Breast Cancer Res; 2016 Dec; 18(1):119. PubMed ID: 27906047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin use and risk of contralateral breast cancer: a nationwide cohort study.
    Langballe R; Cronin-Fenton D; Dehlendorff C; Jensen MB; Ejlertsen B; Andersson M; Friis S; Mellemkjær L
    Br J Cancer; 2018 Nov; 119(10):1297-1305. PubMed ID: 30353047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blocker use and survival after pancreatic cancer surgery: A nationwide population-based cohort study.
    Kirkegård J; Cronin-Fenton D; Lund A; Mortensen FV
    Pharmacoepidemiol Drug Saf; 2024 Jan; 33(1):e5726. PubMed ID: 37946571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of contralateral breast cancer after tamoxifen use among Danish women.
    Mellemkjær L; Steding-Jessen M; Frederiksen K; Andersson M; Ejlertsen B; Jensen MB; Olsen JH
    Ann Epidemiol; 2014 Nov; 24(11):843-8. PubMed ID: 25277504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blocker use and mortality following ovarian cancer diagnosis: a population-based study.
    Couttenier A; Lacroix O; Silversmit G; Vaes E; De Schutter H; Robert A
    Cancer Epidemiol; 2019 Oct; 62():101579. PubMed ID: 31450179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study.
    Gao X; Fisher SG; Emami B
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1038-45. PubMed ID: 12829139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study.
    Langballe R; Mellemkjær L; Malone KE; Lynch CF; John EM; Knight JA; Bernstein L; Brooks J; Andersson M; Reiner AS; Liang X; Woods M; Concannon PJ; ; Bernstein JL
    Breast Cancer Res; 2016 Jul; 18(1):65. PubMed ID: 27400983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Antihypertensive Medications Not Associated with Risk of Contralateral Breast Cancer among Women Diagnosed with Estrogen Receptor-Positive Invasive Breast Cancer.
    Chen L; Malone KE; Li CI
    Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1423-6. PubMed ID: 26084603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related risk factors associated with primary contralateral breast cancer among younger women versus older women.
    Yoon TI; Kwak BS; Yi OV; Kim S; Um E; Yun KW; Shin HN; Lee S; Sohn G; Chung IY; Kim J; Ko BS; Lee JW; Son BH; Ahn SH; Kim HJ
    Breast Cancer Res Treat; 2019 Feb; 173(3):657-665. PubMed ID: 30377870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Race, ethnicity and risk of second primary contralateral breast cancer in the United States.
    Watt GP; John EM; Bandera EV; Malone KE; Lynch CF; Palmer JR; Knight JA; Troester MA; Bernstein JL
    Int J Cancer; 2021 Jun; 148(11):2748-2758. PubMed ID: 33544892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second primary in the contralateral breast after treatment of breast cancer.
    Yadav BS; Sharma SC; Patel FD; Ghoshal S; Kapoor RK
    Radiother Oncol; 2008 Feb; 86(2):171-6. PubMed ID: 17961777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.